Published in Eur J Pharmacol on April 01, 1978
Frequency-dependent, cell type-divergent signaling in the hippocamposeptal projection. J Neurosci (2014) 0.86
Diazepam facilitates the potassium-stimulated release of [3H]-dopamine from rat striatal tissue [proceedings]. Br J Pharmacol (1979) 0.85
Coexistence of carriers for dopamine and GABA uptake on a same nerve terminal in the rat brain. Br J Pharmacol (1987) 0.79
Effects of some amino acids on K+-induced release of [3H]-DA from rat striatal tissue [proceedings]. Br J Pharmacol (1980) 0.79
A Role for Adenosine A1 Receptors in GABA and NMDA-Receptor Mediated Modulation of Dopamine Release: Studies Using Fast Cyclic Voltammetry. Sensors (Basel) (2008) 0.75
Carbon dioxide decreases the intracellular potassium activity in frog muscle [proceedings]. J Physiol (1979) 0.75
Bradykinin and oedema formation in heated paws of rats. Br J Pharmacol Chemother (1967) 2.11
Behavioural depressant and antinociceptive properties of substance P in the mouse: possible implication of brain monoamines. Eur J Pharmacol (1978) 1.40
Enzyme-potentiated hyposensitisation. I. The effect of pre-treatment with -glucuronidase, hyaluronidase, and antigen on anaphylactic sensitivity of guinea-pigs, rats and mice. Int Arch Allergy Appl Immunol (1972) 1.22
The effect of bradykinin and anti-inflammatory agents on isolated arteries. J Pharm Pharmacol (1966) 1.20
The uptake of ( 14 C) -aminobutyric acid by the isolated retina of the rat. Vision Res (1972) 1.19
Inhibition of anaphylactic shock in the rat by antihistamines and ascorbic acid. Br J Pharmacol Chemother (1966) 1.11
Studies in pollen allergy. 3. The relationship between blocking antibody levels and symptomatic relief following hyposensitisation with allpyral in hay fever subjects. Int Arch Allergy Appl Immunol (1970) 1.03
Effects of prostaglandins and a prostaglandin antagonist on intraocular pressure and protein in the monkey eye. Can J Ophthalmol (1971) 0.98
Further studies on the effect of prostaglandin on intraocular pressure in the rabbit. Exp Eye Res (1971) 0.92
Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors. Neuropharmacology (1986) 0.90
Effects of prostaglandin on blood flow in the rabbit eye. Exp Eye Res (1971) 0.89
The efflux of radioactive GABA from rat retina in vitro. Vision Res (1972) 0.89
Effect of inhibitors of -aminobutyrate aminotransferase on the accumulation of 3H- -aminobutyric acid by the retina. Br J Pharmacol (1973) 0.88
Evidence for the participation of nigrotectal gamma-aminobutyrate-containing neurones in striatal and nigral-derived circling in the rat. Neuroscience (1982) 0.88
Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice. Neuropharmacology (1987) 0.82
Effects of glutamate antagonists on the activity of aromatic L-amino acid decarboxylase. Amino Acids (1998) 0.82
Differential behavioural interactions between the dopamine D-1 antagonist SCH 23390 and the dopamine D-2 antagonists metoclopramide and sulpiride in nonhabituated mice. Pharmacol Biochem Behav (1990) 0.82
Studies in pollen allergy. I. A method for estimating histamine release from sensitised leucocytes in the presence of serum. Int Arch Allergy Appl Immunol (1970) 0.81
Involvement of dopamine in circling responses to muscimol depends on intranigral site of injection. Eur J Pharmacol (1981) 0.81
Dopamine and glutamate control each other's release in the basal ganglia: a microdialysis study of the entopeduncular nucleus and substantia nigra. Neurosci Biobehav Rev (1997) 0.80
Motor depression: a new role for D1 receptors? Neuroscience (1990) 0.80
Evidence for a GABAergic nigrothalamic pathway in the rat. I. Behavioural and biochemical studies. Exp Brain Res (1980) 0.80
Evidence for the compartmentation of glutamate metabolism in isolated rat retina. J Neurochem (1974) 0.80
Evidence for a GABAergic nigrothalamic pathway in the rat. II. Electrophysiological studies. Exp Brain Res (1980) 0.79
SKF 38393 and apomorphine modify locomotion and exploration in rats placed on a holeboard by separate actions at dopamine D-1 and D-2 receptors. Eur J Pharmacol (1985) 0.79
Behavioural and biochemical effects of substance P injected into the substantia nigra of the rat. J Pharm Pharmacol (1977) 0.79
Effects of amino-oxyacetic acid, ethanolamine-O-sulphate and GABA on the contents of GABA and various amines in brain slices. J Neurochem (1975) 0.79
Effect of dark adaptation on the GABA system in retina. Brain Res (1973) 0.79
Rotational behaviour elicited by 5-HT in the rat: evidence for an inhibitory role of 5-HT in the substantia nigra and corpus striatum. J Pharm Pharmacol (1980) 0.78
Uptake of taurine by retina in different species. Brain Res (1978) 0.78
Behavioural role of dopamine D1 receptors in the reserpine-treated mouse. Neuroscience (1987) 0.78
GABA-mediated potentiation of amine release from nigrostriatal dopamine neurones in vitro. Eur J Pharmacol (1979) 0.78
Nigral-derived muscimol circling--ipsiversive, contraversive or controversial? Nature (1981) 0.78
Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors. Neuroscience (1993) 0.78
Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours. Neuroscience (1987) 0.78
Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent. Neuroscience (2000) 0.78
The effects of various amino acids, dopamine and some convulsants on the electroretinogram of the rabbit. Exp Eye Res (1975) 0.77
Haemorrhagic, traumatic and tourniquet shock in the rat. J Pharm Pharmacol (1967) 0.77
Role of the ventromedial nucleus of the thalamus in motor behaviour--I. Effects of focal injections of drugs. Neuroscience (1983) 0.77
Regional changes in brain dopamine utilization during status epilepticus in the rat induced by systemic pilocarpine and intrahippocampal carbachol. Neuropharmacology (1996) 0.77
Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390. Pharmacol Biochem Behav (1986) 0.77
Is glycine an inhibitory synaptic transmitter in the substantia nigra? Eur J Pharmacol (1979) 0.77
The uptake, metabolism and release of 14C-taurine by rat retina in vitro. Vision Res (1972) 0.77
Muscarinic action of acetylcholine in the rat ventromedial thalamic nucleus. Exp Brain Res (1984) 0.77
Is the animal's defence against injury and allergic phenomena linked with resistance to the anaphylactoid reaction? Int Arch Allergy Appl Immunol (1967) 0.77
Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata. Brain Res (1997) 0.77
Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat. Neuropharmacology (1990) 0.77
Implantation of dihydrotestosterone propionate into the lateral septum or medial amygdala facilitates copulation in castrated male rats given estradiol systemically. Horm Behav (1982) 0.77
Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801. J Neural Transm Park Dis Dement Sect (1992) 0.77
Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain. Brain Res (2000) 0.77
Prospective neurotransmitters in vertebrate retina. Essays Neurochem Neuropharmacol (1977) 0.77
Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion. Neuroscience (1987) 0.77
D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra. Pharmacol Biochem Behav (1991) 0.77
Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat. Neuroscience (1997) 0.77
Striatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid. Eur J Pharmacol (1999) 0.76
Putative neurotoxicity of SKF 38393 and other D1 dopaminergic drugs investigated in rat striatum. J Neurochem (1992) 0.76
Anticonvulsant effect of striatal dopamine D2 receptor stimulation: dependence on cortical circuits? Neuroscience (1991) 0.76
Antiparkinsonian action of dextromethorphan in the reserpine-treated mouse. Eur J Pharmacol (1995) 0.76
Brain dopamine activity following intranigral or intrathalamic drug injections in the rat. Brain Res Bull (1985) 0.76
Antagonists of glutamate in the treatment of Parkinson's disease: from laboratory to the clinic. Amino Acids (1998) 0.76
Effects of substance P injected into the substantia nigra. Br J Pharmacol (1979) 0.76
Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum. Synapse (1999) 0.76
Role of the ventromedial nucleus of the thalamus in motor behaviour--II. Effects of lesions. Neuroscience (1983) 0.76
NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats. Eur J Pharmacol (1996) 0.76
Disordered dopamine neurotransmission in the striatum of rats undergoing pilocarpine-induced generalized seizures, as revealed by microdialysis. J Neural Transm Park Dis Dement Sect (1993) 0.76
Further evidence for the involvement of kinin in anaphylactic shock in the rat. Br J Pharmacol (1969) 0.75
D1 agonists suppress zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice. Neuroreport (1993) 0.75
Impulse-dependent and tetrodotoxin-sensitive release of GABA in the rat's substantia nigra measured by microdialysis. Brain Res (1995) 0.75
The importance of plasma kinins in the anaphylactoid reaction in rats. Br J Pharmacol Chemother (1967) 0.75
Potentiation by substance P of contractions of the isolated vas deferens of the mouse elicited by electric field stimulation and by drugs. Br J Pharmacol (1978) 0.75
Effects of dopamine D3 receptor agonists on pilocarpine-induced limbic seizures in the rat. Neuroscience (1994) 0.75
Effect of amino-oxyacetic acid on the accumulation of 3H- -aminobutyric acid (3H-GABA) by rat retina. Br J Pharmacol (1973) 0.75
Effects of changes in the ionic composition of the incubation medium on the accumulation and metabolism of 3 H- -aminobutyric acid and 14 C-taurine in isolated rat retina. Biochem Pharmacol (1973) 0.75
The nucleus tegmenti pedunculopontinus and circling behaviour in the rat. Neurosci Lett (1981) 0.75
In morphinised rats SKF 38393 converts dopamine D2 receptor-mediated forward locomotion into backward walking. Pharmacol Biochem Behav (1987) 0.75
Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse. Pharmacol Biochem Behav (1990) 0.75
Effects of metabolic inhibitors on amino acid metabolism in rat retina: a comparison of amino-oxyacetic acid and ethanolamine-o-sulphate. J Neurochem (1975) 0.75
Multiple opiate receptors may be involved in suppressing gamma-aminobutyrate release in substantia nigra. Life Sci (1985) 0.75
Differential effects of pallidal lesions on the behavioural responses to SKF 38393, LY 171555 and apomorphine in the rat. Neuroscience (1989) 0.75
Dysfunction of the midbrain angular complex can accentuate or attenuate circling behaviour in the rat. Exp Brain Res (1985) 0.75
Distribution of gamma-aminobutyrate in the rat thalamus: specific decreases in thalamic gamma-aminobutyrate following lesion or electrical stimulation of the substantia nigra. Neuroscience (1981) 0.75
Specificity of GABA as a stimulator of dopamine release in rat substantia nigra. Neurosci Lett (1980) 0.75
Multifocal brain sites for apomorphine-induced circling and other stereotyped motor behaviour in the 6-hydroxydopamine-lesioned rat. Neurosci Lett (1982) 0.75
Bilateral asymmetry in brain GABA function? Neurosci Lett (1981) 0.75
CY 208-243 behaves as a typical D-1 agonist in the reserpine-treated mouse. Pharmacol Biochem Behav (1991) 0.75
Inhibition of sexual behavior by dopamine antagonist or serotonin agonist drugs in castrated male rats given estradiol or dihydrotestosterone. Pharmacol Biochem Behav (1980) 0.75
Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat. Eur J Pharmacol (1987) 0.75
Relationship between blocking antibody titres and symptomatic relief in hay-fever subjects treated with allpyral. Int Arch Allergy Appl Immunol (1971) 0.75
Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal dopamine D1 receptors. Eur J Pharmacol (1992) 0.75
Interactions between dopamine and gamma-aminobutyrate in the substantia nigra: implications for the striatonigral output hypothesis. Neuroscience (1983) 0.75
Further studies on the process of histamine release from sensitized guinea-pig bone marrow basophils by antigen. Int Arch Allergy Appl Immunol (1970) 0.75
Inability of dextran to release kinin in rats. J Pharm Pharmacol (1970) 0.75
A comparative study of the utilization of glucose, acetate, glutamine and GABA as precursors of amino acids by retinal of the rat, frog, rabbit and pigeon. Biochem Pharmacol (1975) 0.75
Intracerebral SCH 23390 and catalepsy in the rat. Eur J Pharmacol (1988) 0.75
The role of GABA in the substantia nigra. Nature (1978) 0.75
Evidence for the involvement of nigrothalamic GABA neurons in circling behaviour in the rat. Adv Biochem Psychopharmacol (1981) 0.75
Studies in pollen allergy. II. Comparison of leucocyte sensitivity and levels of blocking antibody in hay fever subjects administered allpyral or pollaccine. Int Arch Allergy Appl Immunol (1970) 0.75
Anticonvulsant action of SCH 23390 in the striatum of the rat. Eur J Pharmacol (1990) 0.75
Proconvulsant effect of SKF 38393 mediated by nigral D1 receptors. Eur J Pharmacol (1990) 0.75